Literature DB >> 7504723

Presynaptic inhibition of excitatory synaptic transmission mediated by alpha adrenergic receptors in area CA3 of the rat hippocampus in vitro.

M Scanziani1, B H Gähwiler, S M Thompson.   

Abstract

We have investigated the action of norepinephrine (NE) on excitatory synaptic transmission in the hippocampus by recording from CA3 pyramidal cells in organotypic slice cultures. NE (5 microM) was found to decrease the amplitude of pharmacologically isolated EPSPs elicited with stimulation of mossy fibers or recurrent axon collaterals (mean decrease in EPSP amplitude, 44%). Desensitization was observed with repetitive applications. NE did not affect the sensitivity of CA3 cells to iontophoretically applied AMPA, and did not affect the amplitude distribution of TTX-resistant, miniature excitatory synaptic currents. These data suggest that NE acts at presynaptic receptors to decrease glutamate release. This action of NE was blocked by the alpha receptor antagonist phentolamine and the specific alpha 1 receptor antagonist prazosine, but not by the beta receptor antagonist timolol or the alpha 2 receptor antagonist idazoxan. Inhibition of EPSPs by NE was prevented by pretreatment of cultures with pertussis toxin, indicating that G-proteins couple these receptors to their effectors. Stimulation of protein kinase C with phorbol ester blocked the action of NE on EPSPs. This effect, as well as the desensitization of NE responses, was reduced by application of the protein kinase inhibitor staurosporin. Presynaptic inhibition of excitatory synaptic transmission, mediated by alpha adrenergic receptors, represents a novel modulatory action of NE in the hippocampus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504723      PMCID: PMC6576403     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  20 in total

1.  G-protein alpha subunit isoforms couple differentially to receptors that mediate presynaptic inhibition at rat hippocampal synapses.

Authors:  Alex J Straiker; Catherine R Borden; Jane M Sullivan
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

2.  Changes in AMPA subunit expression in the mouse brain after chronic treatment with the antidepressant maprotiline: a link between noradrenergic and glutamatergic function?

Authors:  Chay-Hoon Tan; Xin He; Jun Yang; Wei-Yi Ong
Journal:  Exp Brain Res       Date:  2005-11-30       Impact factor: 1.972

3.  GABA immunoreactivity in auditory and song control brain areas of zebra finches.

Authors:  Raphael Pinaud; Claudio V Mello
Journal:  J Chem Neuroanat       Date:  2007-03-27       Impact factor: 3.052

4.  Neuroprotection by alpha 2-adrenergic agonists in cerebral ischemia.

Authors:  Yonghua Zhang; Harold K Kimelberg
Journal:  Curr Neuropharmacol       Date:  2005-10       Impact factor: 7.363

5.  Presynaptic alpha2-adrenoceptors control excitatory, but not inhibitory, transmission at rat hippocampal synapses.

Authors:  S Boehm
Journal:  J Physiol       Date:  1999-09-01       Impact factor: 5.182

6.  Differential effects of noradrenaline on evoked, spontaneous and miniature IPSCs in rat cerebellar stellate cells.

Authors:  S Kondo; A Marty
Journal:  J Physiol       Date:  1998-05-15       Impact factor: 5.182

7.  Pore mutation in a G-protein-gated inwardly rectifying K+ channel subunit causes loss of K+-dependent inhibition in weaver hippocampus.

Authors:  W Jarolimek; J Bäurle; U Misgeld
Journal:  J Neurosci       Date:  1998-06-01       Impact factor: 6.167

8.  Effect of amphetamine on the expression of the metabotropic glutamate receptor 5 mRNA in developing rat brain.

Authors:  M F Yu; W M Fu; H S Yin
Journal:  J Mol Neurosci       Date:  2000-12       Impact factor: 3.444

9.  Noradrenergic excitation and inhibition of GABAergic cell types in rat frontal cortex.

Authors:  Y Kawaguchi; T Shindou
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

10.  Dopamine enhances EPSCs in layer II-III pyramidal neurons in rat prefrontal cortex.

Authors:  Carlos Gonzalez-Islas; John J Hablitz
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.